Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1120

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 4
Chunk 1120
---
        
     163,228 
  
    Net
    foreign translation gain 
     -  
     -  
     -  
     -  
     -  
     -  
     61,853  
     61,853  
     -  
     61,853 
  
    Net
    loss 
     -  
     -  
     -  
     -  
     -  
     (3,765,702) 
     -  
     (3,765,702) 
     (48,098) 
     (3,813,800)
  
    Balance—December
    31, 2023 
     78,803  
    $9,858,040  
     96,847  
    $10  
    $27,457,373  
    $(32,580,850) 
    $135,561  
    $4,870,134  
    $(72,038) 
    $4,798,096 

(1)Periods presented have been adjusted to reflect the 1:12 reverse stock split on August 12, 2024 and the 1:5 reverse stock split on February 24, 2025.

See accompanying notes to these consolidated
financial statements which are an integral part of these consolidated financial statements.

F-6

 60 DEGREES
PHARMACEUTICALS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

    For the Years Ended December 31, 
    2024  
    2023 
  
    CASH FLOWS FROM OPERATING ACTIVITIES 

    Net Loss 
    $(7,955,663) 
    $(3,813,800)
  
    Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities: 

    Depreciation 
     11,726  
     21,162 
  
    Amortization 
     38,502  
     29,157 
  
    Amortization of Debt Discount 
     -  
     669,148 
  
    Amortization of ROU Asset 
     13,517  
     50,053 
  
    Amortization of Note Issuance Costs 
     -  
     67